- Supported exchanges /
- F /
- EGQ0.F
INOVIQ LTD. (EGQ0 F) stock market data APIs
INOVIQ Ltd engages in the developing and commercializing of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. Its cancer diagnostic pipeline includes internal and partnered diagnostic tests for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.
INOVIQ LTD. Financial Data Overview
| 0.256 | |
| 0.256 | |
| - | |
| 0.256 | |
| 0.256 | |
| 0.256-0.472 | |
| 30 999 K | |
| 112 M | |
| 1 562 K | |
| 2.041 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
INOVIQ LTD. Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 562 K
- EBITDA -5 642 758
- Earnings Per Share -0.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get INOVIQ LTD. Earnings via APIs
- Latest Release 2024-10-30
- EPS/Forecast NaN
Get INOVIQ LTD. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
